0001209191-22-026096.txt : 20220428 0001209191-22-026096.hdr.sgml : 20220428 20220428195739 ACCESSION NUMBER: 0001209191-22-026096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220426 FILED AS OF DATE: 20220428 DATE AS OF CHANGE: 20220428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zaknoen Sara CENTRAL INDEX KEY: 0001602225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 22869371 MAIL ADDRESS: STREET 1: C/O IGNYTA, INC. STREET 2: 11095 FLINTKOTE AVENUE, SUITE D CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-26 0 0001339970 aTYR PHARMA INC LIFE 0001602225 Zaknoen Sara 3545 JOHN HOPKINS CT. SUITE 250 SAN DIEGO CA 92121 1 0 0 0 Restricted Stock Units 2022-04-26 4 A 0 6000 0.00 A Common Stock 6000 6000 D Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. /s/ Nancy E. Denyes, as Attorney-in-Fact 2022-04-28